Check-Cap Ltd. (CHEK)
NCM · Common · CUSIP M2361E203
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CHEK and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
M2361E203 (prev. M2361E112 )
Market Cap
Micro Cap · $29 Million
Business: Check-Cap Ltd. is a clinical stage medical diagnostics company focused on the development of gastrointestinal imaging devices. The Company's lead product is an endoscopy capsule with a colon imaging system for colorectal cancer and clinically-significant pre-cancerous polyps that utilizes proprietary, ultra-low-energy X-ray-based measurement technology to safely generate high-resolution, 3-dimensional imagery of the colon without cleansing or other aggressive bowel preparation.
Notes: At the commencement of trading on March 18, 2015, the ordinary shares and Series A Warrants will trade separately on the Nasdaq Capital Market under the symbols CHEK and CHEKW respectively. The units, which are currently traded under the symbol CHEKU will no longer be listed on the Nasdaq Capital Market following the separation. Although fractional Series A Warrants will be issued in connection with the separation, no fractional Series A Warrants will trade on the Nasdaq Capital Market.

Company Contact

CEO
Alex Ovadia
CFO
Mira Rosenzweig
Investor Relations
Irina Kofflerr, LifeSci Advisors LLC · 646-970-4681 · jeremy@lifesciadvisors.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »